California X-ray technician dies of cardiac problem  link to second dose of covid-19 vaccine 

By Edward Era Barbacena

An X-ray technician in California whose January death was under investigation as his family suggested a possible link to his second dose of a COVID-19 vaccine died due to heart disease, a coroner’s report concluded. Tim Zook, 60, died of hypertensive and atherosclerotic heart disease with severe cardiomegaly and heart failure, according to his autopsy report. 

The report did not mention a COVID-19 vaccine and said he died at UC Irvine Medical Center. 

At the time of his death, Zook’s widow, Rochelle, told local news outlets that her husband "believed in vaccines" and was "sure he would take that vaccine again, and he’d want the public to take it," but that she noticed his health went into a sharp decline after he received his second dose of the PFIZER shot. 

"We are not blaming any pharmaceutical company," she had told the Orange County Register, before suggesting that his downturn was some sort of a reaction. 

At the time, the Orange County coroner confirmed to Fox News that it was investigating his death and said that "if it’s determined there may be a correlation to the vaccine, we will immediately notify the OC Health Care Agency." 

However, no such correlation was found. 

Pfizer and BioNTech had also confirmed to Fox News at the time that they were aware of Zook’s death and were thoroughly reviewing the matter. 

"Our immediate thoughts are with the bereaved family," a statement provided to Fox News said at the time. "We closely monitor all such events and collect relevant information to share with global regulatory authorities. Based on ongoing safety reviews performed by Pfizer, BioNTech and health authorities, BNT162b2 retains a positive benefit-risk profile for the prevention of COVID-19 infections. Serious adverse events, including deaths that are unrelated to the vaccine, are unfortunately likely to occur at a similar rate as they would in the general population." 

Related articles

Myocarditis after Covid-19 shots is higher than expected in study of US military

Members of the US military  who were inoculated with covid-19 vaccines showed higher than expected rates of heart inflammation or myocarditis though tbe condition may considered as rare according to studies.

The study found out that 23 previously healthy males complained of angina or chest pain four days after given with covid-19 shots. This incident is higher than previously estimated

All patients during that time who complaint of chest pain and who are recovering from the enlargement of the heart ( myocarditis ) were inoculated with covid-19 shots made by Pfizer and Moderna.

US health regulations last added a warning to yhe literature accompanying these mRNA vaccines to flag the rare risk of heart inflammation among young men. But they said that the benefit of these vaccines in preventing Covid-19 continues to rule out the possible risk of myocarditis.

Study shows that 19 who acquired heart inflammation, 19 of them were from active military services and the rest are retired military personels.

Pfizer, Moderna Vaccines Possibly Linked to Rare Heart Inflammation: European Drug Regulator

The European Medicines Agency (EMA) warned Friday that COVID-19 vaccines by Pfizer and Moderna are possibly linked to rare heart inflammation conditions, but emphasized that the benefits of being vaccinated continue to outweigh the risks.

The EMA said the heart conditions, myocarditis and pericarditis, must now be listed as side effects of the two mRNA vaccines, following an analysis of over 300 cases found in vaccinated individuals.

Myocarditis is inflammation of the heart muscle and pericarditis is the inflammation of the lining around the heart. Symptoms of both include chest pain, palpitations and shortness of breath.

In total, the European drug regulator reviewed more than 321 cases of myocarditis and pericarditis found in the European Union, Iceland, Norway and Liechtenstein. Of those, the agency analyzed 145 cases of myocarditis and 138 cases of pericarditis linked to the BioNTech/Pfizer vaccine, and 19 cases of each condition linked to the Moderna vaccine, Politico reported.

The study found that the heart conditions mostly occurred within 14 days of inoculation and typically affected younger men. Most of the cases occurred after inoculation with Pfizer's vaccine, the agency said, while noting that Pfizer's vaccine has been used more widely across Europe than Moderna's.

In response to the findings, Pfizer said in a statement that the cases were "generally mild" and individuals "tend to recover within a short time following standard treatment and rest."